Next Article in Journal
Two Novel er1 Alleles Conferring Powdery Mildew (Erysiphe pisi) Resistance Identified in a Worldwide Collection of Pea (Pisum sativum L.) Germplasms
Next Article in Special Issue
Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis
Previous Article in Journal
Renal Artery Stenosis Alters Gene Expression in Swine Scattered Tubular-Like Cells
Previous Article in Special Issue
Antifibrotic Effects of High-Mobility Group Box 1 Protein Inhibitor (Glycyrrhizin) on Keloid Fibroblasts and Keloid Spheroids through Reduction of Autophagy and Induction of Apoptosis
Open AccessReview

Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis

Department of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, Italy
Division of Internal Medicine, Immunorheumatology Unit, CAAD (Center for Translational Research on Autoimmune and Allergic Disease) “Maggiore della Carità” Hospital, 28100 Novara, Italy
IRCAD, Interdisciplinary Research Center of Autoimmune Diseases, 28100 Novara, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(20), 5070;
Received: 9 September 2019 / Revised: 1 October 2019 / Accepted: 8 October 2019 / Published: 12 October 2019
(This article belongs to the Special Issue Recent Advances in Pathophysiology of Fibrosis and Scarring)
Fibrosis is the result of an overly abundant deposition of extracellular matrix (ECM) due to the fact of repetitive tissue injuries and/or dysregulation of the repair process. Fibrogenesis is a pathogenetic phenomenon which is involved in different chronic human diseases, accounting for a high burden of morbidity and mortality. Despite being triggered by different causative factors, fibrogenesis follows common pathways, the knowledge of which is, however, still unsatisfactory. This represents a significant limit for the development of effective antifibrotic drugs. In the present paper, we aimed to review the current evidence regarding the potential role played in fibrogenesis by growth arrest-specific 6 (Gas6) and its receptors Tyro3 protein tyrosine kinase (Tyro3), Axl receptor tyrosine kinase (Axl), and Mer tyrosine kinase protooncogene (MerTK) (TAM). Moreover, we aimed to review data about the pathogenetic role of this system in the development of different human diseases characterized by fibrosis. Finally, we aimed to explore the potential implications of these findings in diagnosis and treatment. View Full-Text
Keywords: Gas6; Axl; TAM; MerTK; inflammation; fibrosis; cirrhosis; IPF Gas6; Axl; TAM; MerTK; inflammation; fibrosis; cirrhosis; IPF
Show Figures

Figure 1

MDPI and ACS Style

Bellan, M.; Cittone, M.G.; Tonello, S.; Rigamonti, C.; Castello, L.M.; Gavelli, F.; Pirisi, M.; Sainaghi, P.P. Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis. Int. J. Mol. Sci. 2019, 20, 5070.

AMA Style

Bellan M, Cittone MG, Tonello S, Rigamonti C, Castello LM, Gavelli F, Pirisi M, Sainaghi PP. Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis. International Journal of Molecular Sciences. 2019; 20(20):5070.

Chicago/Turabian Style

Bellan, Mattia; Cittone, Micol G.; Tonello, Stelvio; Rigamonti, Cristina; Castello, Luigi M.; Gavelli, Francesco; Pirisi, Mario; Sainaghi, Pier P. 2019. "Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis" Int. J. Mol. Sci. 20, no. 20: 5070.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop